• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群通过肿瘤内自然杀伤细胞调节胰腺癌发生。

Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells.

机构信息

Department of Medicine, University of Florida College of Medicine, Gainesville, Florida, USA.

Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.

出版信息

Gut Microbes. 2022 Jan-Dec;14(1):2112881. doi: 10.1080/19490976.2022.2112881.

DOI:10.1080/19490976.2022.2112881
PMID:35980869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9397420/
Abstract

Preclinical data demonstrate that the gut microbiota can promote pancreatic ductal adenocarcinoma (PDAC), but mechanisms remain unclear. We hypothesized that intestinal microbiota alters anti-tumor innate immunity response to facilitate PDAC progression. Human PDAC L3.6pl cells were heterotopically implanted into mice after microbiota depletion with antibiotics, while syngeneic murine PDAC Pan02 cells were implanted intrapancreatic into germ-free (GF) C57BL/6 J mice. Natural killer (NK) cells and their IFNγ expression were quantitated by flow cytometry. NK cells were depleted in vivo using anti-Asialo GM1 antibody to confirm the role of NK cells. Bacteria-free supernatant from SPF and GF mice feces was used to test its effect on NK-92MI cell anti-tumor response . SPF and ex-GF mice (reconstituted with SPF microbiota) developed larger PDAC tumors with decreased NK cell tumor infiltration and IFNγ expression versus GF-. Microbiota-induced PDAC tumorigenesis was attenuated by antibiotic exposure, a process reversed following NK cell depletion in both and C57BL/6 J mice. Compared to GF, SPF- abiotic stool culture supernatant inhibited NK-92MI cytotoxicity, migration, and anti-cancer related gene expression. Gut microbiota promotes PDAC tumor progression through modulation of the intratumoral infiltration and activity of NK cells.

摘要

临床前数据表明,肠道微生物群可以促进胰腺导管腺癌(PDAC),但其机制尚不清楚。我们假设肠道微生物群改变了抗肿瘤先天免疫反应,从而促进 PDAC 的进展。在抗生素耗尽微生物群后,将人 PDAC L3.6pl 细胞异种植入小鼠,而将同源小鼠 PDAC Pan02 细胞植入无菌(GF)C57BL/6J 小鼠的胰腺内。通过流式细胞术定量测定自然杀伤(NK)细胞及其 IFNγ 的表达。使用抗 Asialo GM1 抗体体内耗尽 NK 细胞,以确认 NK 细胞的作用。使用 SPF 和 GF 小鼠粪便的无细菌上清液来测试其对 NK-92MI 细胞抗肿瘤反应的影响。与 GF 相比,SPF 和 ex-GF 小鼠(用 SPF 微生物群重建)的 PDAC 肿瘤更大,NK 细胞肿瘤浸润和 IFNγ 表达减少。抗生素暴露可减弱微生物群诱导的 PDAC 肿瘤发生,在和 C57BL/6J 小鼠中,NK 细胞耗竭后可逆转这一过程。与 GF 相比,SPF-无生命粪便培养上清液抑制了 NK-92MI 的细胞毒性、迁移和抗癌相关基因的表达。肠道微生物群通过调节肿瘤内 NK 细胞的浸润和活性来促进 PDAC 肿瘤的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad8d/9397420/f1ea50acd269/KGMI_A_2112881_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad8d/9397420/cad6f00acdf6/KGMI_A_2112881_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad8d/9397420/6f25ec3435ce/KGMI_A_2112881_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad8d/9397420/f1ea50acd269/KGMI_A_2112881_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad8d/9397420/cad6f00acdf6/KGMI_A_2112881_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad8d/9397420/6f25ec3435ce/KGMI_A_2112881_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad8d/9397420/f1ea50acd269/KGMI_A_2112881_F0003_OC.jpg

相似文献

1
Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells.肠道微生物群通过肿瘤内自然杀伤细胞调节胰腺癌发生。
Gut Microbes. 2022 Jan-Dec;14(1):2112881. doi: 10.1080/19490976.2022.2112881.
2
Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models.肠道微生物群增强临床前模型中的胰腺发生癌变。
Carcinogenesis. 2018 Jul 30;39(8):1068-1078. doi: 10.1093/carcin/bgy073.
3
DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.DPP 抑制改变了 CXCR3 轴,增强了自然杀伤细胞和 CD8+T 细胞浸润,从而提高了胰腺导管腺癌小鼠模型中抗 PD-1 的疗效。
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-002837.
4
Identification of ONECUT3 as a stemness-related transcription factor regulating NK cell-mediated immune evasion in pancreatic cancer.鉴定 ONECUT3 作为一种与干性相关的转录因子,调节胰腺癌中 NK 细胞介导的免疫逃逸。
Sci Rep. 2023 Oct 24;13(1):18133. doi: 10.1038/s41598-023-45560-y.
5
Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.胰腺星状细胞通过促进胰腺癌小鼠模型中的免疫抑制微环境促进肿瘤进展。
Pancreas. 2020 Jan;49(1):120-127. doi: 10.1097/MPA.0000000000001464.
6
PKCι regulates the expression of PDL1 through multiple pathways to modulate immune suppression of pancreatic cancer cells.蛋白激酶Cι(PKCι)通过多种途径调节程序性死亡配体1(PDL1)的表达,以调节胰腺癌细胞的免疫抑制作用。
Cell Signal. 2021 Oct;86:110115. doi: 10.1016/j.cellsig.2021.110115. Epub 2021 Aug 8.
7
Human microbiota colonization and pancreatic ductal carcinoma.人体微生物定植与胰腺导管腺癌。
Crit Rev Microbiol. 2023 Aug;49(4):455-468. doi: 10.1080/1040841X.2022.2080526. Epub 2022 Aug 4.
8
Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model.TAK-981 通过靶向胰腺癌:一种 SUMOylation 抑制剂,在临床前模型中激活免疫系统并阻断癌细胞周期进程。
Gut. 2022 Nov;71(11):2266-2283. doi: 10.1136/gutjnl-2021-324834. Epub 2022 Jan 24.
9
Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients.NK 细胞在胰腺癌患者中存在定位缺陷及肿瘤细胞毒性受损导致免疫逃逸。
Front Immunol. 2019 Apr 9;10:496. doi: 10.3389/fimmu.2019.00496. eCollection 2019.
10
Deciphering the pancreatic cancer microbiome in Mainland China: Impact of Exiguobacterium/Bacillus ratio on tumor progression and prognostic significance.解读中国大陆胰腺癌微生物群:嗜冷栖芽孢杆菌/芽孢杆菌比例对肿瘤进展的影响及预后意义。
Pharmacol Res. 2024 Jun;204:107197. doi: 10.1016/j.phrs.2024.107197. Epub 2024 Apr 29.

引用本文的文献

1
The gut microbiota in cancer immunity and immunotherapy.癌症免疫与免疫治疗中的肠道微生物群
Cell Mol Immunol. 2025 Aug 6. doi: 10.1038/s41423-025-01326-2.
2
The human microbiome: redefining cancer pathogenesis and therapy.人类微生物组:重新定义癌症发病机制与治疗
Cancer Cell Int. 2025 Apr 28;25(1):165. doi: 10.1186/s12935-025-03787-x.
3
Role of gut microbiome in suppression of cancers.肠道微生物群在癌症抑制中的作用。

本文引用的文献

1
A faecal microbiota signature with high specificity for pancreatic cancer.一种具有高特异性的粪便微生物群特征用于胰腺癌诊断。
Gut. 2022 Jul;71(7):1359-1372. doi: 10.1136/gutjnl-2021-324755. Epub 2022 Mar 8.
2
Finding clues in unexpected places: detection of pancreatic cancer through the faecal microbiome.在意外之处寻找线索:通过粪便微生物群检测胰腺癌
Gut. 2022 Jul;71(7):1247-1248. doi: 10.1136/gutjnl-2021-326710. Epub 2022 Mar 8.
3
NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype.
Gut Microbes. 2025 Dec;17(1):2495183. doi: 10.1080/19490976.2025.2495183. Epub 2025 Apr 20.
4
From Microbiome to Malignancy: Unveiling the Gut Microbiome Dynamics in Pancreatic Carcinogenesis.从微生物组到恶性肿瘤:揭示胰腺癌发生过程中的肠道微生物组动态变化
Int J Mol Sci. 2025 Mar 28;26(7):3112. doi: 10.3390/ijms26073112.
5
Lung commensal bacteria promote lung cancer progression through NK cell-mediated immunosuppressive microenvironment.肺部共生菌通过自然杀伤细胞介导的免疫抑制微环境促进肺癌进展。
Int J Med Sci. 2025 Feb 3;22(5):1039-1051. doi: 10.7150/ijms.107026. eCollection 2025.
6
Dysbiosis-NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes.胰腺癌中微生物群失调与自然杀伤细胞的相互作用:寻求统一生物标志物特征以改善临床结局
Int J Mol Sci. 2025 Jan 16;26(2):730. doi: 10.3390/ijms26020730.
7
Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy.靶向三重自然杀伤细胞抑制机制:胰腺癌治疗中生物标志物的全面综述
Int J Mol Sci. 2025 Jan 9;26(2):515. doi: 10.3390/ijms26020515.
8
Gut microbiota in cancer initiation, development and therapy.肠道微生物群在癌症的起始、发展和治疗中的作用
Sci China Life Sci. 2024 Dec 30. doi: 10.1007/s11427-024-2831-x.
9
A role of gut microbiota metabolites in HLA-E and NKG2 blockage immunotherapy against tumors: new insights for clinical application.肠道微生物群代谢物在 HLA-E 和 NKG2 阻断免疫疗法治疗肿瘤中的作用:临床应用的新见解。
Front Immunol. 2024 Aug 20;15:1331518. doi: 10.3389/fimmu.2024.1331518. eCollection 2024.
10
The intestinal microbiota and cellular therapy: implications for impact and mechanisms.肠道微生物群和细胞治疗:影响和机制的意义。
Blood. 2024 Oct 10;144(15):1557-1569. doi: 10.1182/blood.2024024219.
胰腺癌中的自然杀伤细胞表现出细胞毒性受损和调节性白细胞介素-10表型。
Oncoimmunology. 2020 Nov 19;9(1):1845424. doi: 10.1080/2162402X.2020.1845424.
4
Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer.全球胰腺癌负担、风险因素及趋势。
Gastroenterology. 2021 Feb;160(3):744-754. doi: 10.1053/j.gastro.2020.10.007. Epub 2020 Oct 13.
5
Exploring the NK cell platform for cancer immunotherapy.探索自然杀伤细胞平台在癌症免疫疗法中的应用。
Nat Rev Clin Oncol. 2021 Feb;18(2):85-100. doi: 10.1038/s41571-020-0426-7. Epub 2020 Sep 15.
6
Natural killer cells in cancer biology and therapy.自然杀伤细胞在癌症生物学和治疗中的作用。
Mol Cancer. 2020 Aug 6;19(1):120. doi: 10.1186/s12943-020-01238-x.
7
The human tumor microbiome is composed of tumor type-specific intracellular bacteria.人类肿瘤微生物组由肿瘤类型特异性的内共生细菌组成。
Science. 2020 May 29;368(6494):973-980. doi: 10.1126/science.aay9189.
8
TIMER2.0 for analysis of tumor-infiltrating immune cells.TIMER2.0 用于分析肿瘤浸润免疫细胞。
Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514. doi: 10.1093/nar/gkaa407.
9
Interaction between microbiota and immunity in health and disease.肠道菌群与免疫在健康与疾病中的相互作用。
Cell Res. 2020 Jun;30(6):492-506. doi: 10.1038/s41422-020-0332-7. Epub 2020 May 20.
10
Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice.丁酸钠调节结直肠癌肝转移小鼠的肠道微生物群和免疫反应。
Cell Biol Toxicol. 2020 Oct;36(5):509-515. doi: 10.1007/s10565-020-09518-4. Epub 2020 Mar 14.